Serological Response Patterns of Melanoma Patients Immunized with a GM2 Ganglioside Conjugate Vaccin...
Serological Response Patterns of Melanoma Patients Immunized with a GM2 Ganglioside Conjugate Vaccine
About this item
Full title
Author / Creator
Publisher
United States: National Academy of Sciences of the United States of America
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences of the United States of America
Subjects
More information
Scope and Contents
Contents
Gangliosides, such as GM2, GD2, GD3, and 9-O-acetyl GD3, are receiving attention as targets for antibody-based and vaccine-based therapies of melanoma. GM2 appears to be a particularly immunogenic ganglioside in humans, as indicated by the presence of naturally occurring IgM anti-GM2 antibodies in ≈5% of humans and the fact that immunization with i...
Alternative Titles
Full title
Serological Response Patterns of Melanoma Patients Immunized with a GM2 Ganglioside Conjugate Vaccine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pnas_primary_92_7_2805
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pnas_primary_92_7_2805
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.92.7.2805
